Gene and functional up-regulation of the BCRP/ABCG2 transporter in hepatocellular carcinoma

Gene and functional up-regulation of the BCRP/ABCG2 transporter in hepatocellular carcinoma

The Breast Cancer Resistance Protein (BCRP/ABCG2) is one member of ABC transporters proteins super family responsible of drug resistance. Since data on ABCG2 expression in liver malignances are scanty, here we report the expression of ABCG2 in adult human hepatocellular carcinoma (HCC) in both in vi...

Shranjeno v:

Bibliografske podrobnosti
Main Authors:	Caecilia Sukowati, Natalia Rosso, Devis Pascut, Beatrice Anfuso, Giuliano Torre, Paola Francalanci, Lory Saveria Crocè, Claudio Tiribelli
Format:	Artigo
Jezik:	angleščina
Izdano:	2012
Online dostop:	https://doi.org/10.1186/1471-230x-12-160 https://bmcgastroenterol.biomedcentral.com/counter/pdf/10.1186/1471-230X-12-160
Oznake:	Označite Brez oznak, prvi označite!

Podobne knjige/članki

Gene and functional up-regulation of the BCRP/ABCG2 transporter in hepatocellular carcinoma
od: Sukowati, Caecilia HC, et al.
Izdano: (2012)

The Expression of CD90/Thy-1 in Hepatocellular Carcinoma: An In Vivo and In Vitro Study
od: Caecilia Sukowati, et al.
Izdano: (2013)

The Expression of CD90/Thy-1 in Hepatocellular Carcinoma: An In Vivo and In Vitro Study
od: Sukowati, Caecilia Hapsari Ceriapuri, et al.
Izdano: (2013)

The role of multipotent cancer associated fibroblasts in hepatocarcinogenesis
od: Caecilia Sukowati, et al.
Izdano: (2015)

The role of multipotent cancer associated fibroblasts in hepatocarcinogenesis
od: Sukowati, Caecilia Hapsari Ceriapuri, et al.
Izdano: (2015)

Hepatic cancer stem cells and drug resistance: Relevance in targeted therapies for hepatocellular carcinoma
od: Sukowati, Caecilia HC, et al.
Izdano: (2010)

Serum AP-endonuclease 1 (sAPE1) as novel biomarker for hepatocellular carcinoma
od: Devis Pascut, et al.
Izdano: (2019)

Serum Stem Cell Growth Factor Beta for the Prediction of Therapy Response in Hepatocellular Carcinoma
od: Sukowati, Caecilia H. C., et al.
Izdano: (2018)

Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma
od: Rusdina Bte Ladju, et al.
Izdano: (2017)

Serum AP-endonuclease 1 (sAPE1) as novel biomarker for hepatocellular carcinoma
od: Pascut, Devis, et al.
Izdano: (2019)

Circulating Long and Circular Noncoding RNA as Non-Invasive Diagnostic Tools of Hepatocellular Carcinoma
od: Sukowati, Caecilia H. C., et al.
Izdano: (2021)

Circulatory miRNA as a Biomarker for Therapy Response and Disease-Free Survival in Hepatocellular Carcinoma
od: Pratama, Muhammad Yogi, et al.
Izdano: (2020)

Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma
od: Ladju, Rusdina Bte, et al.
Izdano: (2017)

Correction: Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma
od: Ladju, Rusdina Bte, et al.
Izdano: (2018)

Weighted miRNA co-expression networks analysis identifies circulating miRNA predicting overall survival in hepatocellular carcinoma patients
od: Pascut, Devis, et al.
Izdano: (2020)

A comparative characterization of the circulating miRNome in whole blood and serum of HCC patients
od: Pascut, Devis, et al.
Izdano: (2019)

A comparative characterization of the circulating miRNome in whole blood and serum of HCC patients
od: Devis Pascut, et al.
Izdano: (2019)

Repeated double cross-validation applied to the PCA-LDA classification of SERS spectra: a case study with serum samples from hepatocellular carcinoma patients
od: Gurian, Elisa, et al.
Izdano: (2020)

Repeated double cross-validation applied to the PCA-LDA classification of SERS spectra: a case study with serum samples from hepatocellular carcinoma patients
od: Elisa Gurian, et al.
Izdano: (2020)

The Relevance of SOCS1 Methylation and Epigenetic Therapy in Diverse Cell Populations of Hepatocellular Carcinoma
od: Cabral, Loraine Kay D., et al.
Izdano: (2021)

Sorafenib Resistance in Hepatocellular Carcinoma: The Relevance of Genetic Heterogeneity
od: Loraine Kay D. Cabral, et al.
Izdano: (2020)

Sorafenib Resistance in Hepatocellular Carcinoma: The Relevance of Genetic Heterogeneity
od: Cabral, Loraine Kay D., et al.
Izdano: (2020)

BCRP/ABCG2 Inhibition Sensitizes Hepatocellular Carcinoma Cells to Sorafenib
od: Huang, Wei-Chien, et al.
Izdano: (2013)

BCRP/ABCG2 Inhibition Sensitizes Hepatocellular Carcinoma Cells to Sorafenib
od: Wei‐Chien Huang, et al.
Izdano: (2013)

The role of microRNA in the resistance to treatment of hepatocellular carcinoma
od: Pratama, Muhammad Yogi, et al.
Izdano: (2019)

The role of microRNA in the resistance to treatment of hepatocellular carcinoma
od: Muhammad Yogi Pratama, et al.
Izdano: (2019)

Immunotherapy against programmed death-1/programmed death ligand 1 in hepatocellular carcinoma: Importance of molecular variations, cellular heterogeneity, and cancer stem cells
od: Sukowati, Caecilia H C, et al.
Izdano: (2021)

Silencing efficacy prediction: a retrospective study on target mRNA features
od: Pascut, Devis, et al.
Izdano: (2015)

Activation of hepatic stem cells compartment during hepatocarcinogenesis in a HBsAg HBV-transgenic mouse model
od: Anfuso, Beatrice, et al.
Izdano: (2018)

Hyaluronic acid inhibition by 4-methylumbelliferone reduces the expression of cancer stem cells markers during hepatocarcinogenesis
od: Sukowati, Caecilia H. C., et al.
Izdano: (2019)

Obeticholic acid and INT-767 modulate collagen deposition in a NASH in vitro model
od: Anfuso, Beatrice, et al.
Izdano: (2020)

Obeticholic acid and INT-767 modulate collagen deposition in a NASH in vitro model
od: Beatrice Anfuso, et al.
Izdano: (2020)

Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma
od: Caecilia Sukowati
Izdano: (2016)

BCRP/ABCG2 in the Placenta: Expression, Function and Regulation
od: Mao, Qingcheng
Izdano: (2008)

BCRP/ABCG2 in the Placenta: Expression, Function and Regulation
od: Mao, Qingcheng
Izdano: (2008)

BCRP/ABCG2 in the Placenta: Expression, Function and Regulation
od: Qingcheng Mao
Izdano: (2008)

HCC occurrence after DAA treatments: molecular tools to assess the post-treatment risk and surveillance
od: Pascut, Devis, et al.
Izdano: (2020)

Selection and validation of miR-1280 as a suitable endogenous normalizer for qRT-PCR Analysis of serum microRNA expression in Hepatocellular Carcinoma
od: Pratama, Muhammad Yogi, et al.
Izdano: (2020)

The Crosstalk between Tumor Cells and the Microenvironment in Hepatocellular Carcinoma: The Role of Exosomal microRNAs and Their Clinical Implications
od: Pascut, Devis, et al.
Izdano: (2020)

Biomarkers for the Detection and Management of Hepatocellular Carcinoma in Patients Treated with Direct-Acting Antivirals
od: Cabral, Loraine Kay D., et al.
Izdano: (2022)